INmune Bio Inc.'s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy : vimarsana.com

Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening Session BOCA RATON, Fla., May 24, 2023 --  INmune Bio Inc. announces that Mark Lowdell,... | June 11, 2023

Related Keywords

Paris , France General , France , Inmune Bio , Jason Nelson , David Moss , Mark Lowdell , Md Inmune Bio , Matt Rettig , International Society Of Cell , Prostate Cancer Program , Inmune Bio Inc , David Geffen School Of Medicine , Company Current Reports On Form , Drug Administration , Nasdaq , Company Annual Report On Form , Exchange Commission , Company Quarterly Reports On Form , Globe Newswire Inmune Bio Inc , Presidential Plenary , Presented Wednesday , Presidential Symposium , International Society , Gene Therapy , Immune Effector Cell Therapies , Tumor Primed Memory , Clinical Trials , Natural Killer , Investigational New Drug Application , Medical Director , David Geffen School , Jonsson Comprehensive Cancer , Dominant Negative Tumor Necrosis Factor , Mild Alzheimer , Mild Cognitive Impairment , Natural Killer Cell Priming Platform , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,